Durabook Announces “Vanguard Partner Program” Enrichment to Channel Partners Program 
Home games nearly double the crowd: World Cup WiFi data shows what the quarter final is worth to UK pubs, so Purple is dressing their WiFi in the England flag for free Fuse Science, Inc. Shareholder Update and Announcement of Kustomeroo
JACKSONVILLE, FL / ACCESSWIRE / July 2, 2021 / Fuse Science, Inc.(OTC PINK:DROP), The company…
i3 Energy PLC Announces Operational Update
EASTLEIGH, UK / ACCESSWIRE / July 1, 2021 / i3 Energy plc (AIM:I3E)(TSX:ITE), an independent…
Telecom sector to benefit from B2B Telecom & Datacom Marketplace
Telecoms and datacom marketplace Twoosk provides the top ten reasons to go virtual Aveiro, Portugal,…
HUTCHMED to Announce 2021 Half-Year Financial Results
HONG KONG and SHANGHAI, China and & FLORHAM PARK, N.J., July 02, 2021 (GLOBE NEWSWIRE)…
Philogen Announces R&D Program Update
Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP…
Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial
Press Release Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial July…
Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of dRTA
Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of…
ObsEva to Present Ebopiprant (OBE022) Data at the Society for Reproductive Investigation 68th Annual Meeting
-Data from PROLONG Phase 2a proof-of-concept study of ebopiprant (OBE022) for spontaneous preterm labor to be…
Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock
CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated…
Junshi Biosciences Appoints Wei Qian as Chief Commerical Officer
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a…
Hangzhou Chance Pharmaceuticals Announces NMPA Acceptance of Marketing Authorization Application for CXF11
HANGZHOU, China, July 02, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology…
Iterum Therapeutics Provides Regulatory Update
DUBLIN, Ireland and CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
CytoDyn Submits Dose Justification Report to FDA to Begin Overcoming Deficiencies in its BLA for HIV
Management works to advance its BLA filing seeking FDA approval for leronlimab as a combination…
Ensysce Biosciences to Begin Trading its Common Stock on The Nasdaq Capital Market on July 2, 2021
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Better Choice Announces Closing of $40M Underwritten Public Offering
NEW YORK, July 01, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE American: BTTR) (“Better…
ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
RESEARCH TRIANGLE PARK, N.C., July 01, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the Treatment of TGM-1 Associated Ichthyosis
– New data include update from the fourth patient treated in the Phase 1/2 trial…
Oncternal Therapeutics Appoints Pablo Urbaneja as Sr. Vice President, Corporate Development
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions
SALT LAKE CITY, July 01, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…
Bioasis Announces the Appointment of Dave Jenkins as Chief Financial Officer
NEW HAVEN, Conn., July 01, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…